Melanoma vasculogenic mimicry is strongly related to reactive oxygen species level

Melanoma Research

Volumn 17, Issue 6, 2007, Pages 370-379

  Vartanian, Amalia A ^a   Burova, Olga S ^a   Stepanova, Eugeniya V ^a   Baryshnikov, Anatoly Yu ^a   Lichinitser, Mikhail R ^a  

^a N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

Author keywords

Antioxidant; Melanoma; Vasculogenic mimicry

Indexed keywords

ACETYLCYSTEINE; ANTINEOPLASTIC AGENT; ANTIOXIDANT; CASPASE 3; EPIGALLOCATHECHIN GALLATE; REACTIVE OXYGEN METABOLITE; RESVERATROL; TROLOX C; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL ACTIVITY; CELL FUNCTION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; MELANOMA; MELANOMA CELL; MOLECULAR GENETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN BLOOD VESSEL DISORDER; WESTERN BLOTTING;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTIOXIDANTS; APOPTOSIS; CAPILLARIES; CASPASE 3; CELL LINE, TUMOR; CYTOCHROMES C; FEMALE; HUMANS; MELANOMA; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PATHOLOGIC; REACTIVE OXYGEN SPECIES; STILBENES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 36049043422     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/CMR.0b013e3282f1d2ec     Document Type: Article

References (37)

1. Folkman J. Fundamental concepts of the angiogenic process. Curr Mol Med 2003; 3:643-651.
2. Folberg R, Pe'er J, Gruman LM, Wooloson RF, Jeng G, Montague PR, et al. The morphological characteristics of tumor blood vessels as a marker of tumor progression in primary human melanoma: a matched case-control study. Hum Pathol 1992; 23:1298-1305.
3. Makitie T, Summanen P, Tarkkanen A, Kivela T. Microvascular loops and networks as prognostic indicators in choroidal and ciliary body melanomas. J Natl Cancer Inst 1999; 91:359-367.
4. Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LMG, Pe'er J, et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 1999; 55:739-752.
5. Maniotis AJ, Chen X, Garcia C, DeChristopher PJ, Wu D, Pe'er J, et al. Control of melanoma morphogenesis, endothelial survival and perfusion by extracellular matrix. Lab Invest 2002; 82:1031-1043.
6. Hendrix MJ, Seftor EA, Hess AR, Seftor R. Molecular plasticity of human melanoma cells. Oncogene 2003; 22:3070-3075.
7. Warso MA, Maniotis AJ, Chen X, Majumdar D, Patel MK, Shilkaitis A, et al. Prognostic significance of periodic acid-Schiff-positive patterns in primary cutaneous melanoma. Clin Cancer Res 2001; 7:473-477.
8. Clarijs R, Otte-Holler I, Ruiter DJ, de Waal RM. Presence of a fluidconducting meshwork in xenografted cutaneous and primary human uveal melanoma. Invest Ophtalmol Vis Sci 2002; 43:912-918.
9. Forguson K. Melanoma. J Cont Educ Nurs 2005; 36:242-243.
10. Mandara M, Nortilli R, Sava T, Cetto GL. Chemotherapy for metastatic melanoma. Expert Rev Anticancer Ther 2006; 6:121-130.
11. Bedikian AY. Metastatic uveal melanoma therapy: current options. Int Ophthalmol Clin 2006; 46:151-166.
12. Demierre MF, Natanson L. Chemoprevention of melanoma: an unexpected strategy. J Clin Oncol 2003; 21:158-165.
13. Mukhtar H, Ahmad N. Green tea in chemoprevention of cancer. Toxicol Sci 1999; 52:111-117.
14. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1999; 275:218-220.
15. Fujiki H. Two stages of cancer prevention with green tea. J Cancer Res Clin Oncol 1999; 125:589-597.
16. Soleas GJ, Diamandis EP, Goldbery DM. Resveratrol: a molecule whose time has come? And gone? Clin Biochem 1997; 30:91-113.
17. Mikhailova IN, Lukashina MI, Baryshnikov AYu, Morozova LF, Kisselev CL, et al. Melanoma cell lines as a basis for antitumor vaccine preparation. Vest Ross Akad Med Nauk 2005; 7:37-40.
18. 2 determination in cultured endothelial cells. Arch Biochem Biophys 1993; 302:348-355.
19. Endl E, Gerdes J. Ki-67 protein: fascinating forms and unknown functions. Exp Cell Res 2000; 257:231-237.
20. Brakenhielm E, Cao R, Cao Y. Suppression of angiogenesis, tumor growth and wound healing by resveratrol, a natural compound in red wine and grapes. FAZEB J 2001; 15:1798-1800.
21. Lamy S, Gingras D, Beliveau R. Green tea catechins inhibit vascular endothelial growth factor receptor phosphorylation. Cancer Res 2002; 62:381-385.
22. Garcia-Garcia J, Micol V, de Godes A, Gomes-Fernandes JC. The cancer chemopreventive agent resveratrol is incorporated into model membranes and inhibits protein kinase C alpha activity. Arch Biochem Biophys 1999; 372:382-388.
23. Manna SK, Mukhopadhyay A, Aggarwal BB. Resveratrol suppress TNF-induced activation of NF-kappa B, activator protein-1 and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J Immunol 2000; 164:6509-6519.
24. Masood R, Cai J, Zheng T, Smith DL, Hinton DR, Gill PS. Vascular endothelial growth factor is an autocrine growth factor for VEGF receptorpositive human tumors. Blood 2001; 98:1904-1913.
25. Vartanian AA, Stepanova EV, Burova OS, Baryshnikov Au. The involvement of apoptosis in melanoma vasculogenic mimicry. Melanoma Res 2007; 1:1-8.
26. Vartanian AA, Stepanova EV, Baryshnikov AYu, Lichinitser MR. Melanoma vasculogenic mimicry and apoptosis. Dokl Akad Nauk 2005; 402:129-132.
27. Schulze-Osthoff K, Ferrari D, Loss M. Apoptosis signaling by death receptors. Eur J Biochem 1998; 17:1675-1687.
28. Meier P, Finch A, Evan G. Apoptosis in development. Nature 2000; 407:796-801.
29. Van der Schaft DWI, Seftor REB, Seftor EA, Hess AR, Gruman LM, Kirschmann DA, et al. Effects of angiogenesis inhibitors on vascular network formation by human endothelial and melanoma cells. J Natl Cancer Inst 2004; 96:1473-1476.
30. Meykens FL, Farmer P, Fruehanf JP. Redox regulation in human melanocytes and melanoma. Pigm Cell Res 2001; 14:148-152.
31. Yasuda M, Ohzeki Y, Shimizu S, Naito S, Ohtsuru A, Yamamoto T, et al. Stimulation of in vitro angiogenesis by hydrogen peroxide and the relation with ETS-1 in endothelial cells. Life Sci 1999; 64:249-258.
32. Stone JR, Collins T. The role of hydrogen peroxide in endothelial proliferative response. Endothelium 2002; 9:231-238.
33. Ugurel S, Rappl B, Tilgen W, Reinhold U. Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival. J Clin Oncol 2001; 76:930-934.
34. Malafa MP, Fokum FD, Smith L, Louis A. Inhibition of angiogenesis and promotion of melanoma dormancy by Vit E succinate. Ann Surg Oncol 2002; 9:1023-1032.
35. Lee YK, Bone ND, Strege AK, Shanafelt TD, Jelinek DF, Kay NE. VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemia. Blood 2004; 104:788-794.
36. Veikkola T, Karkainen M, Clarson-Welsh L, Alitalo K. Regulation of angiogenesis via vascular endothelial growth factor receptors. Cancer Res 2000; 60:203-212.
37. Garrido C, Kroemer G. Life's smile, death grin: vital function of apoptosis-executing proteins. Curr Opin Cell Biol 2004; 16:639-646.